nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—CYP2C19—Methazolamide—glaucoma	0.064	0.142	CbGbCtD
Lapatinib—CYP3A5—Clonidine—glaucoma	0.0573	0.127	CbGbCtD
Lapatinib—CYP2C19—Timolol—glaucoma	0.0544	0.121	CbGbCtD
Lapatinib—CYP3A4—Pilocarpine—glaucoma	0.0458	0.101	CbGbCtD
Lapatinib—ABCB1—Timolol—glaucoma	0.0439	0.0973	CbGbCtD
Lapatinib—ABCB1—Clonidine—glaucoma	0.0373	0.0827	CbGbCtD
Lapatinib—CYP3A4—Brinzolamide—glaucoma	0.0359	0.0796	CbGbCtD
Lapatinib—CYP3A4—Dorzolamide—glaucoma	0.0347	0.0769	CbGbCtD
Lapatinib—CYP3A4—Methazolamide—glaucoma	0.0309	0.0685	CbGbCtD
Lapatinib—CYP3A4—Acetazolamide—glaucoma	0.0247	0.0548	CbGbCtD
Lapatinib—CYP3A4—Clonidine—glaucoma	0.0224	0.0495	CbGbCtD
Lapatinib—PIK3C2B—Epinephrine—Dipivefrin—glaucoma	0.00963	1	CbGdCrCtD
Lapatinib—Myalgia—Travoprost—glaucoma	0.000762	0.00248	CcSEcCtD
Lapatinib—Arthralgia—Travoprost—glaucoma	0.000762	0.00248	CcSEcCtD
Lapatinib—Leukopenia—Pilocarpine—glaucoma	0.00076	0.00248	CcSEcCtD
Lapatinib—Pneumonia—Betaxolol—glaucoma	0.00076	0.00248	CcSEcCtD
Lapatinib—Nausea—Carteolol—glaucoma	0.000758	0.00247	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.000756	0.00247	CcSEcCtD
Lapatinib—Headache—Levobunolol—glaucoma	0.000756	0.00246	CcSEcCtD
Lapatinib—Infestation NOS—Betaxolol—glaucoma	0.000755	0.00246	CcSEcCtD
Lapatinib—Infestation—Betaxolol—glaucoma	0.000755	0.00246	CcSEcCtD
Lapatinib—Nervous system disorder—Brimonidine—glaucoma	0.000753	0.00245	CcSEcCtD
Lapatinib—Myalgia—Brinzolamide—glaucoma	0.000752	0.00245	CcSEcCtD
Lapatinib—Arthralgia—Brinzolamide—glaucoma	0.000752	0.00245	CcSEcCtD
Lapatinib—Palpitations—Pilocarpine—glaucoma	0.00075	0.00245	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000749	0.00244	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.000747	0.00243	CcSEcCtD
Lapatinib—Skin disorder—Brimonidine—glaucoma	0.000746	0.00243	CcSEcCtD
Lapatinib—Nausea—Diclofenamide—glaucoma	0.000746	0.00243	CcSEcCtD
Lapatinib—Cough—Pilocarpine—glaucoma	0.000741	0.00242	CcSEcCtD
Lapatinib—Neuropathy peripheral—Betaxolol—glaucoma	0.00074	0.00241	CcSEcCtD
Lapatinib—Stomatitis—Betaxolol—glaucoma	0.000736	0.0024	CcSEcCtD
Lapatinib—Vomiting—Methazolamide—glaucoma	0.000735	0.0024	CcSEcCtD
Lapatinib—Anaphylactic shock—Dorzolamide—glaucoma	0.000733	0.00239	CcSEcCtD
Lapatinib—Gastrointestinal pain—Apraclonidine—glaucoma	0.000731	0.00238	CcSEcCtD
Lapatinib—Rash—Methazolamide—glaucoma	0.000729	0.00238	CcSEcCtD
Lapatinib—Dermatitis—Methazolamide—glaucoma	0.000728	0.00237	CcSEcCtD
Lapatinib—Nausea—Carbachol—glaucoma	0.000728	0.00237	CcSEcCtD
Lapatinib—Infection—Travoprost—glaucoma	0.000725	0.00236	CcSEcCtD
Lapatinib—Headache—Methazolamide—glaucoma	0.000724	0.00236	CcSEcCtD
Lapatinib—Cardiac disorder—Clonidine—glaucoma	0.000723	0.00236	CcSEcCtD
Lapatinib—Myalgia—Pilocarpine—glaucoma	0.000723	0.00236	CcSEcCtD
Lapatinib—Arthralgia—Pilocarpine—glaucoma	0.000723	0.00236	CcSEcCtD
Lapatinib—Nausea—Levobunolol—glaucoma	0.000717	0.00234	CcSEcCtD
Lapatinib—Infection—Brinzolamide—glaucoma	0.000716	0.00233	CcSEcCtD
Lapatinib—Nervous system disorder—Travoprost—glaucoma	0.000716	0.00233	CcSEcCtD
Lapatinib—Epistaxis—Betaxolol—glaucoma	0.000712	0.00232	CcSEcCtD
Lapatinib—Skin disorder—Travoprost—glaucoma	0.000709	0.00231	CcSEcCtD
Lapatinib—Abdominal pain—Apraclonidine—glaucoma	0.000707	0.0023	CcSEcCtD
Lapatinib—Nervous system disorder—Brinzolamide—glaucoma	0.000707	0.0023	CcSEcCtD
Lapatinib—Angiopathy—Clonidine—glaucoma	0.000707	0.0023	CcSEcCtD
Lapatinib—Rash—Latanoprost—glaucoma	0.000705	0.0023	CcSEcCtD
Lapatinib—Dermatitis—Latanoprost—glaucoma	0.000705	0.0023	CcSEcCtD
Lapatinib—Dyspepsia—Acetazolamide—glaucoma	0.000704	0.0023	CcSEcCtD
Lapatinib—Mediastinal disorder—Clonidine—glaucoma	0.000702	0.00229	CcSEcCtD
Lapatinib—Headache—Latanoprost—glaucoma	0.000701	0.00228	CcSEcCtD
Lapatinib—Skin disorder—Brinzolamide—glaucoma	0.0007	0.00228	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Brimonidine—glaucoma	0.0007	0.00228	CcSEcCtD
Lapatinib—Anorexia—Dorzolamide—glaucoma	0.000699	0.00228	CcSEcCtD
Lapatinib—Decreased appetite—Acetazolamide—glaucoma	0.000695	0.00227	CcSEcCtD
Lapatinib—Insomnia—Brimonidine—glaucoma	0.000694	0.00226	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000691	0.00225	CcSEcCtD
Lapatinib—Fatigue—Acetazolamide—glaucoma	0.00069	0.00225	CcSEcCtD
Lapatinib—Infection—Pilocarpine—glaucoma	0.000688	0.00224	CcSEcCtD
Lapatinib—Alopecia—Clonidine—glaucoma	0.000688	0.00224	CcSEcCtD
Lapatinib—Nausea—Methazolamide—glaucoma	0.000687	0.00224	CcSEcCtD
Lapatinib—Dyspnoea—Brimonidine—glaucoma	0.000685	0.00223	CcSEcCtD
Lapatinib—Mental disorder—Clonidine—glaucoma	0.000682	0.00222	CcSEcCtD
Lapatinib—Dyspepsia—Brimonidine—glaucoma	0.000676	0.0022	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000668	0.00218	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Travoprost—glaucoma	0.000665	0.00217	CcSEcCtD
Lapatinib—Insomnia—Dorzolamide—glaucoma	0.000663	0.00216	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Brimonidine—glaucoma	0.000663	0.00216	CcSEcCtD
Lapatinib—Fatigue—Brimonidine—glaucoma	0.000662	0.00216	CcSEcCtD
Lapatinib—Anorexia—Pilocarpine—glaucoma	0.00066	0.00215	CcSEcCtD
Lapatinib—Hypersensitivity—Apraclonidine—glaucoma	0.000659	0.00215	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000657	0.00214	CcSEcCtD
Lapatinib—Dyspnoea—Dorzolamide—glaucoma	0.000654	0.00213	CcSEcCtD
Lapatinib—Insomnia—Brinzolamide—glaucoma	0.000652	0.00213	CcSEcCtD
Lapatinib—Dyspnoea—Travoprost—glaucoma	0.000651	0.00212	CcSEcCtD
Lapatinib—Dyspepsia—Dorzolamide—glaucoma	0.000645	0.0021	CcSEcCtD
Lapatinib—Dyspnoea—Brinzolamide—glaucoma	0.000643	0.0021	CcSEcCtD
Lapatinib—Dyspepsia—Travoprost—glaucoma	0.000643	0.0021	CcSEcCtD
Lapatinib—Asthenia—Apraclonidine—glaucoma	0.000642	0.00209	CcSEcCtD
Lapatinib—Decreased appetite—Dorzolamide—glaucoma	0.000637	0.00208	CcSEcCtD
Lapatinib—Dyspepsia—Brinzolamide—glaucoma	0.000635	0.00207	CcSEcCtD
Lapatinib—Pruritus—Apraclonidine—glaucoma	0.000633	0.00206	CcSEcCtD
Lapatinib—Fatigue—Dorzolamide—glaucoma	0.000632	0.00206	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000631	0.00206	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Travoprost—glaucoma	0.00063	0.00206	CcSEcCtD
Lapatinib—Fatigue—Travoprost—glaucoma	0.000629	0.00205	CcSEcCtD
Lapatinib—Cardiac disorder—Betaxolol—glaucoma	0.000629	0.00205	CcSEcCtD
Lapatinib—Insomnia—Pilocarpine—glaucoma	0.000627	0.00204	CcSEcCtD
Lapatinib—Decreased appetite—Brinzolamide—glaucoma	0.000627	0.00204	CcSEcCtD
Lapatinib—Constipation—Travoprost—glaucoma	0.000624	0.00204	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000622	0.00203	CcSEcCtD
Lapatinib—Asthenia—Bimatoprost—glaucoma	0.000622	0.00203	CcSEcCtD
Lapatinib—Fatigue—Brinzolamide—glaucoma	0.000622	0.00203	CcSEcCtD
Lapatinib—Dyspnoea—Pilocarpine—glaucoma	0.000618	0.00201	CcSEcCtD
Lapatinib—Angiopathy—Betaxolol—glaucoma	0.000615	0.00201	CcSEcCtD
Lapatinib—Pruritus—Bimatoprost—glaucoma	0.000614	0.002	CcSEcCtD
Lapatinib—Immune system disorder—Betaxolol—glaucoma	0.000612	0.002	CcSEcCtD
Lapatinib—Diarrhoea—Apraclonidine—glaucoma	0.000612	0.00199	CcSEcCtD
Lapatinib—Mediastinal disorder—Betaxolol—glaucoma	0.000611	0.00199	CcSEcCtD
Lapatinib—Dyspepsia—Pilocarpine—glaucoma	0.00061	0.00199	CcSEcCtD
Lapatinib—Decreased appetite—Pilocarpine—glaucoma	0.000602	0.00196	CcSEcCtD
Lapatinib—Gastrointestinal pain—Dorzolamide—glaucoma	0.0006	0.00195	CcSEcCtD
Lapatinib—Alopecia—Betaxolol—glaucoma	0.000599	0.00195	CcSEcCtD
Lapatinib—Palpitations—Clonidine—glaucoma	0.000599	0.00195	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000598	0.00195	CcSEcCtD
Lapatinib—Gastrointestinal pain—Travoprost—glaucoma	0.000597	0.00195	CcSEcCtD
Lapatinib—Mental disorder—Betaxolol—glaucoma	0.000594	0.00194	CcSEcCtD
Lapatinib—Constipation—Pilocarpine—glaucoma	0.000593	0.00193	CcSEcCtD
Lapatinib—Cough—Clonidine—glaucoma	0.000592	0.00193	CcSEcCtD
Lapatinib—Malnutrition—Betaxolol—glaucoma	0.00059	0.00192	CcSEcCtD
Lapatinib—Epistaxis—Timolol—glaucoma	0.000582	0.0019	CcSEcCtD
Lapatinib—Abdominal pain—Dorzolamide—glaucoma	0.00058	0.00189	CcSEcCtD
Lapatinib—Arthralgia—Clonidine—glaucoma	0.000577	0.00188	CcSEcCtD
Lapatinib—Abdominal pain—Travoprost—glaucoma	0.000577	0.00188	CcSEcCtD
Lapatinib—Asthenia—Acetazolamide—glaucoma	0.000574	0.00187	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000573	0.00187	CcSEcCtD
Lapatinib—Vomiting—Apraclonidine—glaucoma	0.000569	0.00185	CcSEcCtD
Lapatinib—Gastrointestinal pain—Pilocarpine—glaucoma	0.000567	0.00185	CcSEcCtD
Lapatinib—Hypersensitivity—Brimonidine—glaucoma	0.000566	0.00184	CcSEcCtD
Lapatinib—Dermatitis—Apraclonidine—glaucoma	0.000563	0.00184	CcSEcCtD
Lapatinib—Headache—Apraclonidine—glaucoma	0.00056	0.00183	CcSEcCtD
Lapatinib—Asthenia—Brimonidine—glaucoma	0.000551	0.0018	CcSEcCtD
Lapatinib—Infection—Clonidine—glaucoma	0.00055	0.00179	CcSEcCtD
Lapatinib—Abdominal pain—Pilocarpine—glaucoma	0.000548	0.00179	CcSEcCtD
Lapatinib—Diarrhoea—Acetazolamide—glaucoma	0.000547	0.00178	CcSEcCtD
Lapatinib—Rash—Bimatoprost—glaucoma	0.000547	0.00178	CcSEcCtD
Lapatinib—Dermatitis—Bimatoprost—glaucoma	0.000546	0.00178	CcSEcCtD
Lapatinib—Anaemia—Betaxolol—glaucoma	0.000546	0.00178	CcSEcCtD
Lapatinib—Connective tissue disorder—Timolol—glaucoma	0.000544	0.00177	CcSEcCtD
Lapatinib—Pruritus—Brimonidine—glaucoma	0.000543	0.00177	CcSEcCtD
Lapatinib—Headache—Bimatoprost—glaucoma	0.000543	0.00177	CcSEcCtD
Lapatinib—Nervous system disorder—Clonidine—glaucoma	0.000543	0.00177	CcSEcCtD
Lapatinib—Hypersensitivity—Dorzolamide—glaucoma	0.00054	0.00176	CcSEcCtD
Lapatinib—Hypersensitivity—Travoprost—glaucoma	0.000538	0.00175	CcSEcCtD
Lapatinib—Skin disorder—Clonidine—glaucoma	0.000537	0.00175	CcSEcCtD
Lapatinib—Nausea—Apraclonidine—glaucoma	0.000531	0.00173	CcSEcCtD
Lapatinib—Hypersensitivity—Brinzolamide—glaucoma	0.000531	0.00173	CcSEcCtD
Lapatinib—Anorexia—Clonidine—glaucoma	0.000527	0.00172	CcSEcCtD
Lapatinib—Asthenia—Dorzolamide—glaucoma	0.000526	0.00172	CcSEcCtD
Lapatinib—Asthenia—Travoprost—glaucoma	0.000524	0.00171	CcSEcCtD
Lapatinib—Palpitations—Betaxolol—glaucoma	0.000522	0.0017	CcSEcCtD
Lapatinib—Pruritus—Dorzolamide—glaucoma	0.000519	0.00169	CcSEcCtD
Lapatinib—Asthenia—Brinzolamide—glaucoma	0.000517	0.00169	CcSEcCtD
Lapatinib—Pruritus—Travoprost—glaucoma	0.000517	0.00168	CcSEcCtD
Lapatinib—Cough—Betaxolol—glaucoma	0.000515	0.00168	CcSEcCtD
Lapatinib—Nausea—Bimatoprost—glaucoma	0.000515	0.00168	CcSEcCtD
Lapatinib—Cardiac disorder—Timolol—glaucoma	0.000514	0.00168	CcSEcCtD
Lapatinib—Hypersensitivity—Pilocarpine—glaucoma	0.000511	0.00166	CcSEcCtD
Lapatinib—Pruritus—Brinzolamide—glaucoma	0.00051	0.00166	CcSEcCtD
Lapatinib—Vomiting—Acetazolamide—glaucoma	0.000509	0.00166	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Clonidine—glaucoma	0.000504	0.00164	CcSEcCtD
Lapatinib—Angiopathy—Timolol—glaucoma	0.000503	0.00164	CcSEcCtD
Lapatinib—Myalgia—Betaxolol—glaucoma	0.000503	0.00164	CcSEcCtD
Lapatinib—Arthralgia—Betaxolol—glaucoma	0.000503	0.00164	CcSEcCtD
Lapatinib—Diarrhoea—Dorzolamide—glaucoma	0.000502	0.00164	CcSEcCtD
Lapatinib—Headache—Acetazolamide—glaucoma	0.000501	0.00163	CcSEcCtD
Lapatinib—Insomnia—Clonidine—glaucoma	0.0005	0.00163	CcSEcCtD
Lapatinib—Immune system disorder—Timolol—glaucoma	0.0005	0.00163	CcSEcCtD
Lapatinib—Diarrhoea—Travoprost—glaucoma	0.0005	0.00163	CcSEcCtD
Lapatinib—Mediastinal disorder—Timolol—glaucoma	0.000499	0.00163	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000499	0.00163	CcSEcCtD
Lapatinib—Asthenia—Pilocarpine—glaucoma	0.000497	0.00162	CcSEcCtD
Lapatinib—Dyspnoea—Clonidine—glaucoma	0.000493	0.00161	CcSEcCtD
Lapatinib—Diarrhoea—Brinzolamide—glaucoma	0.000493	0.00161	CcSEcCtD
Lapatinib—Pruritus—Pilocarpine—glaucoma	0.00049	0.0016	CcSEcCtD
Lapatinib—Alopecia—Timolol—glaucoma	0.000489	0.0016	CcSEcCtD
Lapatinib—Mental disorder—Timolol—glaucoma	0.000485	0.00158	CcSEcCtD
Lapatinib—Rash—Brimonidine—glaucoma	0.000484	0.00158	CcSEcCtD
Lapatinib—Dermatitis—Brimonidine—glaucoma	0.000484	0.00158	CcSEcCtD
Lapatinib—Malnutrition—Timolol—glaucoma	0.000482	0.00157	CcSEcCtD
Lapatinib—Headache—Brimonidine—glaucoma	0.000481	0.00157	CcSEcCtD
Lapatinib—Decreased appetite—Clonidine—glaucoma	0.000481	0.00157	CcSEcCtD
Lapatinib—Infection—Betaxolol—glaucoma	0.000479	0.00156	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Clonidine—glaucoma	0.000478	0.00156	CcSEcCtD
Lapatinib—Fatigue—Clonidine—glaucoma	0.000477	0.00156	CcSEcCtD
Lapatinib—Nausea—Acetazolamide—glaucoma	0.000475	0.00155	CcSEcCtD
Lapatinib—Diarrhoea—Pilocarpine—glaucoma	0.000474	0.00155	CcSEcCtD
Lapatinib—Constipation—Clonidine—glaucoma	0.000473	0.00154	CcSEcCtD
Lapatinib—Nervous system disorder—Betaxolol—glaucoma	0.000472	0.00154	CcSEcCtD
Lapatinib—Skin disorder—Betaxolol—glaucoma	0.000468	0.00153	CcSEcCtD
Lapatinib—Vomiting—Dorzolamide—glaucoma	0.000466	0.00152	CcSEcCtD
Lapatinib—Rash—Dorzolamide—glaucoma	0.000462	0.00151	CcSEcCtD
Lapatinib—Dermatitis—Dorzolamide—glaucoma	0.000462	0.00151	CcSEcCtD
Lapatinib—Rash—Travoprost—glaucoma	0.00046	0.0015	CcSEcCtD
Lapatinib—Dermatitis—Travoprost—glaucoma	0.00046	0.0015	CcSEcCtD
Lapatinib—Headache—Dorzolamide—glaucoma	0.000459	0.0015	CcSEcCtD
Lapatinib—Anorexia—Betaxolol—glaucoma	0.000459	0.0015	CcSEcCtD
Lapatinib—Vomiting—Brinzolamide—glaucoma	0.000458	0.00149	CcSEcCtD
Lapatinib—Headache—Travoprost—glaucoma	0.000457	0.00149	CcSEcCtD
Lapatinib—Nausea—Brimonidine—glaucoma	0.000456	0.00149	CcSEcCtD
Lapatinib—Rash—Brinzolamide—glaucoma	0.000455	0.00148	CcSEcCtD
Lapatinib—Dermatitis—Brinzolamide—glaucoma	0.000454	0.00148	CcSEcCtD
Lapatinib—Gastrointestinal pain—Clonidine—glaucoma	0.000452	0.00148	CcSEcCtD
Lapatinib—Headache—Brinzolamide—glaucoma	0.000452	0.00147	CcSEcCtD
Lapatinib—Vomiting—Pilocarpine—glaucoma	0.000441	0.00144	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000439	0.00143	CcSEcCtD
Lapatinib—Abdominal pain—Clonidine—glaucoma	0.000437	0.00143	CcSEcCtD
Lapatinib—Rash—Pilocarpine—glaucoma	0.000437	0.00142	CcSEcCtD
Lapatinib—Dermatitis—Pilocarpine—glaucoma	0.000436	0.00142	CcSEcCtD
Lapatinib—Insomnia—Betaxolol—glaucoma	0.000436	0.00142	CcSEcCtD
Lapatinib—Nausea—Dorzolamide—glaucoma	0.000436	0.00142	CcSEcCtD
Lapatinib—Headache—Pilocarpine—glaucoma	0.000434	0.00142	CcSEcCtD
Lapatinib—Nausea—Travoprost—glaucoma	0.000434	0.00141	CcSEcCtD
Lapatinib—Dyspnoea—Betaxolol—glaucoma	0.000429	0.0014	CcSEcCtD
Lapatinib—Nausea—Brinzolamide—glaucoma	0.000428	0.0014	CcSEcCtD
Lapatinib—Palpitations—Timolol—glaucoma	0.000426	0.00139	CcSEcCtD
Lapatinib—Dyspepsia—Betaxolol—glaucoma	0.000424	0.00138	CcSEcCtD
Lapatinib—Cough—Timolol—glaucoma	0.000421	0.00137	CcSEcCtD
Lapatinib—Decreased appetite—Betaxolol—glaucoma	0.000419	0.00137	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Betaxolol—glaucoma	0.000416	0.00136	CcSEcCtD
Lapatinib—Fatigue—Betaxolol—glaucoma	0.000415	0.00135	CcSEcCtD
Lapatinib—Constipation—Betaxolol—glaucoma	0.000412	0.00134	CcSEcCtD
Lapatinib—Nausea—Pilocarpine—glaucoma	0.000412	0.00134	CcSEcCtD
Lapatinib—Arthralgia—Timolol—glaucoma	0.000411	0.00134	CcSEcCtD
Lapatinib—Myalgia—Timolol—glaucoma	0.000411	0.00134	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000408	0.00133	CcSEcCtD
Lapatinib—Hypersensitivity—Clonidine—glaucoma	0.000408	0.00133	CcSEcCtD
Lapatinib—Asthenia—Clonidine—glaucoma	0.000397	0.00129	CcSEcCtD
Lapatinib—Anaphylactic shock—Timolol—glaucoma	0.000394	0.00128	CcSEcCtD
Lapatinib—Pruritus—Clonidine—glaucoma	0.000391	0.00128	CcSEcCtD
Lapatinib—Infection—Timolol—glaucoma	0.000391	0.00127	CcSEcCtD
Lapatinib—Nervous system disorder—Timolol—glaucoma	0.000386	0.00126	CcSEcCtD
Lapatinib—Skin disorder—Timolol—glaucoma	0.000382	0.00125	CcSEcCtD
Lapatinib—Diarrhoea—Clonidine—glaucoma	0.000379	0.00123	CcSEcCtD
Lapatinib—Anorexia—Timolol—glaucoma	0.000375	0.00122	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Timolol—glaucoma	0.000359	0.00117	CcSEcCtD
Lapatinib—Insomnia—Timolol—glaucoma	0.000356	0.00116	CcSEcCtD
Lapatinib—Hypersensitivity—Betaxolol—glaucoma	0.000355	0.00116	CcSEcCtD
Lapatinib—Vomiting—Clonidine—glaucoma	0.000352	0.00115	CcSEcCtD
Lapatinib—Dyspnoea—Timolol—glaucoma	0.000351	0.00114	CcSEcCtD
Lapatinib—Rash—Clonidine—glaucoma	0.000349	0.00114	CcSEcCtD
Lapatinib—Dermatitis—Clonidine—glaucoma	0.000349	0.00114	CcSEcCtD
Lapatinib—Headache—Clonidine—glaucoma	0.000347	0.00113	CcSEcCtD
Lapatinib—Dyspepsia—Timolol—glaucoma	0.000346	0.00113	CcSEcCtD
Lapatinib—Asthenia—Betaxolol—glaucoma	0.000346	0.00113	CcSEcCtD
Lapatinib—Decreased appetite—Timolol—glaucoma	0.000342	0.00112	CcSEcCtD
Lapatinib—Pruritus—Betaxolol—glaucoma	0.000341	0.00111	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Timolol—glaucoma	0.00034	0.00111	CcSEcCtD
Lapatinib—Fatigue—Timolol—glaucoma	0.000339	0.00111	CcSEcCtD
Lapatinib—Diarrhoea—Betaxolol—glaucoma	0.00033	0.00107	CcSEcCtD
Lapatinib—Nausea—Clonidine—glaucoma	0.000329	0.00107	CcSEcCtD
Lapatinib—Gastrointestinal pain—Timolol—glaucoma	0.000322	0.00105	CcSEcCtD
Lapatinib—Abdominal pain—Timolol—glaucoma	0.000311	0.00101	CcSEcCtD
Lapatinib—Vomiting—Betaxolol—glaucoma	0.000306	0.000999	CcSEcCtD
Lapatinib—Rash—Betaxolol—glaucoma	0.000304	0.00099	CcSEcCtD
Lapatinib—Dermatitis—Betaxolol—glaucoma	0.000303	0.000989	CcSEcCtD
Lapatinib—Headache—Betaxolol—glaucoma	0.000302	0.000984	CcSEcCtD
Lapatinib—Hypersensitivity—Timolol—glaucoma	0.00029	0.000945	CcSEcCtD
Lapatinib—Nausea—Betaxolol—glaucoma	0.000286	0.000933	CcSEcCtD
Lapatinib—Asthenia—Timolol—glaucoma	0.000282	0.000921	CcSEcCtD
Lapatinib—Pruritus—Timolol—glaucoma	0.000278	0.000908	CcSEcCtD
Lapatinib—Diarrhoea—Timolol—glaucoma	0.000269	0.000878	CcSEcCtD
Lapatinib—Vomiting—Timolol—glaucoma	0.00025	0.000816	CcSEcCtD
Lapatinib—Rash—Timolol—glaucoma	0.000248	0.000809	CcSEcCtD
Lapatinib—Dermatitis—Timolol—glaucoma	0.000248	0.000808	CcSEcCtD
Lapatinib—Headache—Timolol—glaucoma	0.000247	0.000804	CcSEcCtD
Lapatinib—Nausea—Timolol—glaucoma	0.000234	0.000762	CcSEcCtD
Lapatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—CDKN1B—glaucoma	9.17e-05	0.000394	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—NOS3—glaucoma	8.98e-05	0.000386	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	8.9e-05	0.000383	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—CDKN1B—glaucoma	8.75e-05	0.000377	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—CDKN1B—glaucoma	8.75e-05	0.000377	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—CDKN1B—glaucoma	8.75e-05	0.000377	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	8.69e-05	0.000374	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—NOS3—glaucoma	8.67e-05	0.000373	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—CDKN1B—glaucoma	8.67e-05	0.000373	CbGpPWpGaD
Lapatinib—CYP2C19—Biological oxidations—GSTM1—glaucoma	8.67e-05	0.000373	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—TNF—glaucoma	8.63e-05	0.000371	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—CDKN1B—glaucoma	8.59e-05	0.00037	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—BAD—glaucoma	8.56e-05	0.000368	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—CDKN1B—glaucoma	8.56e-05	0.000368	CbGpPWpGaD
Lapatinib—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	8.55e-05	0.000368	CbGpPWpGaD
Lapatinib—EGFR—Immune System—C1QB—glaucoma	8.42e-05	0.000363	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—VEGFA—glaucoma	8.26e-05	0.000356	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	8.23e-05	0.000354	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—PTGS2—glaucoma	8.21e-05	0.000353	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	8.2e-05	0.000353	CbGpPWpGaD
Lapatinib—CYP3A4—Biological oxidations—GSTT1—glaucoma	8.18e-05	0.000352	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	8.15e-05	0.000351	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—OPN4—glaucoma	8.1e-05	0.000349	CbGpPWpGaD
Lapatinib—EGFR—B Cell Activation—CDKN1B—glaucoma	8.1e-05	0.000348	CbGpPWpGaD
Lapatinib—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	8.09e-05	0.000348	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—PTGS2—glaucoma	7.93e-05	0.000341	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—CDKN1B—glaucoma	7.75e-05	0.000334	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL1A—glaucoma	7.71e-05	0.000332	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	7.62e-05	0.000328	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—SMO—glaucoma	7.61e-05	0.000328	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—TP53—glaucoma	7.6e-05	0.000327	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL1A—glaucoma	7.6e-05	0.000327	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HEYL—glaucoma	7.53e-05	0.000324	CbGpPWpGaD
Lapatinib—EGFR—Immune System—TXN—glaucoma	7.51e-05	0.000323	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—SMO—glaucoma	7.5e-05	0.000323	CbGpPWpGaD
Lapatinib—ERBB2—Disease—CDKN2B—glaucoma	7.47e-05	0.000321	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—MMP9—glaucoma	7.37e-05	0.000317	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CDKN2B—glaucoma	7.35e-05	0.000317	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PTGFR—glaucoma	7.3e-05	0.000314	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—CDKN1B—glaucoma	7.03e-05	0.000303	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—VEGFA—glaucoma	7e-05	0.000301	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	6.98e-05	0.0003	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—NTRK2—glaucoma	6.96e-05	0.0003	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—CDKN1B—glaucoma	6.93e-05	0.000298	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—VEGFA—glaucoma	6.88e-05	0.000296	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—NTRK2—glaucoma	6.86e-05	0.000295	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	6.85e-05	0.000295	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—C3—glaucoma	6.78e-05	0.000292	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—CDKN1B—glaucoma	6.75e-05	0.000291	CbGpPWpGaD
Lapatinib—EGFR—Disease—HDAC9—glaucoma	6.71e-05	0.000289	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—C3—glaucoma	6.68e-05	0.000287	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—CDKN1B—glaucoma	6.65e-05	0.000286	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—MMP2—glaucoma	6.65e-05	0.000286	CbGpPWpGaD
Lapatinib—EGFR—Direct p53 effectors—TP53—glaucoma	6.63e-05	0.000285	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—VEGFA—glaucoma	6.62e-05	0.000285	CbGpPWpGaD
Lapatinib—CYP3A4—Biological oxidations—CYP1B1—glaucoma	6.52e-05	0.000281	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—TNF—glaucoma	6.5e-05	0.00028	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—BCL2L1—glaucoma	6.49e-05	0.000279	CbGpPWpGaD
Lapatinib—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	6.43e-05	0.000277	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—BCL2L1—glaucoma	6.39e-05	0.000275	CbGpPWpGaD
Lapatinib—ERBB2—Disease—MTHFR—glaucoma	6.26e-05	0.000269	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—TP53—glaucoma	6.24e-05	0.000269	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—SMO—glaucoma	6.23e-05	0.000268	CbGpPWpGaD
Lapatinib—ERBB4—Disease—MTHFR—glaucoma	6.16e-05	0.000265	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CA1—glaucoma	6.03e-05	0.000259	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—TNF—glaucoma	6e-05	0.000258	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—NGFR—glaucoma	5.97e-05	0.000257	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	5.97e-05	0.000257	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—CDKN1B—glaucoma	5.96e-05	0.000257	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—NGFR—glaucoma	5.88e-05	0.000253	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—BAD—glaucoma	5.88e-05	0.000253	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	5.87e-05	0.000253	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CTSA—glaucoma	5.84e-05	0.000251	CbGpPWpGaD
Lapatinib—ERBB2—Disease—APOE—glaucoma	5.83e-05	0.000251	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—BAD—glaucoma	5.79e-05	0.000249	CbGpPWpGaD
Lapatinib—ERBB2—Disease—CAV1—glaucoma	5.77e-05	0.000248	CbGpPWpGaD
Lapatinib—ERBB4—Disease—APOE—glaucoma	5.74e-05	0.000247	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CA5A—glaucoma	5.74e-05	0.000247	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—NARFL—glaucoma	5.74e-05	0.000247	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—TP53—glaucoma	5.73e-05	0.000247	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—RPTOR—glaucoma	5.71e-05	0.000246	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CAV1—glaucoma	5.69e-05	0.000245	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—TNF—glaucoma	5.67e-05	0.000244	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—NTRK1—glaucoma	5.67e-05	0.000244	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—C3—glaucoma	5.63e-05	0.000242	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—NTRK1—glaucoma	5.59e-05	0.000241	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.58e-05	0.00024	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NCK2—glaucoma	5.53e-05	0.000238	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CA2—glaucoma	5.51e-05	0.000237	CbGpPWpGaD
Lapatinib—ERBB2—Disease—BAD—glaucoma	5.43e-05	0.000234	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—C3—glaucoma	5.4e-05	0.000233	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—BCL2L1—glaucoma	5.39e-05	0.000232	CbGpPWpGaD
Lapatinib—ERBB4—Disease—BAD—glaucoma	5.35e-05	0.00023	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CDKN2B—glaucoma	5.23e-05	0.000225	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CA1—glaucoma	5.22e-05	0.000225	CbGpPWpGaD
Lapatinib—CYP3A4—Biological oxidations—GSTM1—glaucoma	5.21e-05	0.000224	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	5.17e-05	0.000223	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CDKN2B—glaucoma	5.15e-05	0.000222	CbGpPWpGaD
Lapatinib—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	5.14e-05	0.000221	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CTSA—glaucoma	5.05e-05	0.000218	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—EDN1—glaucoma	5.02e-05	0.000216	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—MMP9—glaucoma	5e-05	0.000215	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—EDN1—glaucoma	4.94e-05	0.000213	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—BAD—glaucoma	4.88e-05	0.00021	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CA2—glaucoma	4.77e-05	0.000205	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—MMP2—glaucoma	4.74e-05	0.000204	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HDAC9—glaucoma	4.7e-05	0.000202	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—BAD—glaucoma	4.69e-05	0.000202	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.67e-05	0.000201	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.67e-05	0.000201	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CA1—glaucoma	4.66e-05	0.000201	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—NGF—glaucoma	4.61e-05	0.000198	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CA1—glaucoma	4.55e-05	0.000196	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—NGF—glaucoma	4.54e-05	0.000195	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CTSA—glaucoma	4.51e-05	0.000194	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—VEGFA—glaucoma	4.49e-05	0.000193	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CTSA—glaucoma	4.4e-05	0.00019	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	4.39e-05	0.000189	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—C3—glaucoma	4.38e-05	0.000189	CbGpPWpGaD
Lapatinib—ERBB2—Disease—NOS3—glaucoma	4.36e-05	0.000188	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—C3—glaucoma	4.32e-05	0.000186	CbGpPWpGaD
Lapatinib—ERBB4—Disease—NOS3—glaucoma	4.3e-05	0.000185	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CA2—glaucoma	4.26e-05	0.000183	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.16e-05	0.000179	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.16e-05	0.000179	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CA2—glaucoma	4.16e-05	0.000179	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	4.15e-05	0.000179	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—EDN1—glaucoma	4.11e-05	0.000177	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CDKN1B—glaucoma	4.1e-05	0.000176	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—APOE—glaucoma	4.08e-05	0.000176	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CAV1—glaucoma	4.04e-05	0.000174	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CDKN1B—glaucoma	4.03e-05	0.000174	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—APOE—glaucoma	4.02e-05	0.000173	CbGpPWpGaD
Lapatinib—ERBB2—Disease—PTGS2—glaucoma	3.99e-05	0.000172	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CAV1—glaucoma	3.98e-05	0.000171	CbGpPWpGaD
Lapatinib—ERBB4—Disease—PTGS2—glaucoma	3.93e-05	0.000169	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—TXN—glaucoma	3.88e-05	0.000167	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—FN1—glaucoma	3.85e-05	0.000166	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—BAD—glaucoma	3.8e-05	0.000164	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—FN1—glaucoma	3.79e-05	0.000163	CbGpPWpGaD
Lapatinib—ERBB2—Disease—CDKN1B—glaucoma	3.78e-05	0.000163	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—BAD—glaucoma	3.74e-05	0.000161	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL1A—glaucoma	3.73e-05	0.000161	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CDKN1B—glaucoma	3.72e-05	0.00016	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SMO—glaucoma	3.68e-05	0.000158	CbGpPWpGaD
Lapatinib—EGFR—Disease—CDKN2B—glaucoma	3.61e-05	0.000155	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—C3—glaucoma	3.59e-05	0.000154	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—MMP9—glaucoma	3.56e-05	0.000153	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	3.46e-05	0.000149	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CDKN1B—glaucoma	3.4e-05	0.000146	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NTRK2—glaucoma	3.36e-05	0.000145	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—TXN—glaucoma	3.36e-05	0.000145	CbGpPWpGaD
Lapatinib—EGFR—Immune System—C3—glaucoma	3.28e-05	0.000141	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CDKN1B—glaucoma	3.26e-05	0.00014	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—VEGFA—glaucoma	3.2e-05	0.000138	CbGpPWpGaD
Lapatinib—EGFR—Immune System—BCL2L1—glaucoma	3.14e-05	0.000135	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.07e-05	0.000132	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—NOS3—glaucoma	3.06e-05	0.000132	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.04e-05	0.000131	CbGpPWpGaD
Lapatinib—EGFR—Disease—MTHFR—glaucoma	3.03e-05	0.00013	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—NOS3—glaucoma	3.01e-05	0.00013	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GSTT1—glaucoma	3.01e-05	0.00013	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—TXN—glaucoma	3e-05	0.000129	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	2.96e-05	0.000127	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—TXN—glaucoma	2.93e-05	0.000126	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NGFR—glaucoma	2.89e-05	0.000124	CbGpPWpGaD
Lapatinib—EGFR—Immune System—BAD—glaucoma	2.84e-05	0.000122	CbGpPWpGaD
Lapatinib—EGFR—Disease—APOE—glaucoma	2.82e-05	0.000121	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CA1—glaucoma	2.8e-05	0.000121	CbGpPWpGaD
Lapatinib—EGFR—Disease—CAV1—glaucoma	2.79e-05	0.00012	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—TNF—glaucoma	2.74e-05	0.000118	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NTRK1—glaucoma	2.74e-05	0.000118	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.74e-05	0.000118	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.71e-05	0.000117	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CTSA—glaucoma	2.71e-05	0.000117	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CDKN1B—glaucoma	2.65e-05	0.000114	CbGpPWpGaD
Lapatinib—EGFR—Disease—BAD—glaucoma	2.62e-05	0.000113	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.61e-05	0.000112	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CDKN1B—glaucoma	2.61e-05	0.000112	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GSTT1—glaucoma	2.61e-05	0.000112	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CA2—glaucoma	2.56e-05	0.00011	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CDKN2B—glaucoma	2.53e-05	0.000109	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—MMP9—glaucoma	2.45e-05	0.000106	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—EDN1—glaucoma	2.43e-05	0.000104	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—MMP9—glaucoma	2.42e-05	0.000104	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CYP1B1—glaucoma	2.4e-05	0.000103	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ABCA1—glaucoma	2.4e-05	0.000103	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GSTT1—glaucoma	2.33e-05	0.0001	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GSTT1—glaucoma	2.27e-05	9.78e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NGF—glaucoma	2.23e-05	9.59e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—VEGFA—glaucoma	2.2e-05	9.48e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—VEGFA—glaucoma	2.17e-05	9.34e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—C3—glaucoma	2.12e-05	9.12e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—NOS3—glaucoma	2.11e-05	9.08e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.1e-05	9.05e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ABCA1—glaucoma	2.08e-05	8.94e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CYP1B1—glaucoma	2.08e-05	8.94e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CDKN1B—glaucoma	1.98e-05	8.52e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—APOE—glaucoma	1.97e-05	8.49e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CAV1—glaucoma	1.95e-05	8.41e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—PTGS2—glaucoma	1.93e-05	8.31e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GSTM1—glaucoma	1.92e-05	8.25e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.88e-05	8.08e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—FN1—glaucoma	1.86e-05	8.01e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CYP1B1—glaucoma	1.85e-05	7.98e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ABCA1—glaucoma	1.85e-05	7.98e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—BAD—glaucoma	1.84e-05	7.91e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—CDKN1B—glaucoma	1.83e-05	7.87e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CYP1B1—glaucoma	1.81e-05	7.79e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ABCA1—glaucoma	1.81e-05	7.79e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—TXN—glaucoma	1.81e-05	7.77e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—MTHFR—glaucoma	1.69e-05	7.29e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TP53—glaucoma	1.66e-05	7.16e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GSTM1—glaucoma	1.66e-05	7.15e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TP53—glaucoma	1.64e-05	7.05e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—APOE—glaucoma	1.58e-05	6.79e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CAV1—glaucoma	1.56e-05	6.73e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GSTM1—glaucoma	1.48e-05	6.38e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NOS3—glaucoma	1.48e-05	6.36e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—MTHFR—glaucoma	1.47e-05	6.32e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GSTM1—glaucoma	1.45e-05	6.23e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GSTT1—glaucoma	1.4e-05	6.02e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—APOE—glaucoma	1.37e-05	5.88e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CAV1—glaucoma	1.35e-05	5.83e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—MTHFR—glaucoma	1.31e-05	5.64e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CDKN1B—glaucoma	1.28e-05	5.51e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—MTHFR—glaucoma	1.28e-05	5.5e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—APOE—glaucoma	1.22e-05	5.25e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CAV1—glaucoma	1.21e-05	5.2e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—APOE—glaucoma	1.19e-05	5.12e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MMP9—glaucoma	1.19e-05	5.1e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—NOS3—glaucoma	1.18e-05	5.09e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CAV1—glaucoma	1.18e-05	5.08e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ABCA1—glaucoma	1.12e-05	4.8e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CYP1B1—glaucoma	1.12e-05	4.8e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PTGS2—glaucoma	1.08e-05	4.65e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—VEGFA—glaucoma	1.06e-05	4.58e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—NOS3—glaucoma	1.02e-05	4.41e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PTGS2—glaucoma	9.36e-06	4.03e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—NOS3—glaucoma	9.14e-06	3.93e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—NOS3—glaucoma	8.92e-06	3.84e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GSTM1—glaucoma	8.92e-06	3.84e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PTGS2—glaucoma	8.36e-06	3.6e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PTGS2—glaucoma	8.16e-06	3.51e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TP53—glaucoma	8.04e-06	3.46e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—MTHFR—glaucoma	7.88e-06	3.39e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—APOE—glaucoma	7.34e-06	3.16e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CAV1—glaucoma	7.27e-06	3.13e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—NOS3—glaucoma	5.5e-06	2.37e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PTGS2—glaucoma	5.03e-06	2.16e-05	CbGpPWpGaD
